Follow The Filings

ARTL Artelo Biosciences

Artelo Biosciences earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01
8-K 3.03,5.03,7.01,9.01
10-Q/A FORM 10-Q/A
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q FORM 10-Q
8-K 5.07
DEFA14A
DEFA14A
DEFA14A
DEF 14A
DEFA14A
8-K 1.01,8.01,9.01
424B5
424B5 FORM 424B5
SCHEDULE 13G —
8-K 1.02
10-Q FORM 10-Q
424B3
8-K 8.01,9.01
S-1 FORM S-1
SCHEDULE 13G —
8-K 1.01,3.02,7.01,8.01,9.01
8-K 1.01,3.02,7.01,9.01
S-1/A FORM-S-1/A

Insider forms

Forms 3, 4 and 5 from EDGAR, 1 row shown

Filed Form Detail Links
4 Period Jul 17, 2026 (5 forms)

1 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.